Page 210 - Mercy MOR All Regions_FinalwVideo

Youngstown Variance % Variance 1.0% $14,901,486
Key Performance Indicators Net Patient Revenue $1,875 $71,128,973 ($2,349,650) -3.3% $69,202,224
Budget
Actual
Metric
Prior
$14,967,311
Supply Expense
$15,121,578
$154,267
$68,779,323
21.8%
21.3%
0.5%
2.3%
Supply Expense % Net Patient Revenue
21.5%
Supply Expense per EIPA
$1,867
$1,837
-2.1%
($38)
3,794
Total Admissions
-0.9%
3,759
(35)
3,827
26,079
1.8%
460
26,074

25,619
Total Patient Days
7,983
(251)
8,232
-3.0%
7,981
Total EIPAs

IP Surgeries
1,215
1,345

OP Surgeries
1,295
130
10.7%
-2.5%
1,738
(44)

1,782
Total Surgeries
1,882
3.6%
140
169
6
Outpatient Cath Lab Procedures 393 568 (175) -30.8% 587
175

Site Performance Summary
Mercy Health Youngstown expense arrived at budget for the month at $110K (0.7% variance). Gross revenue fell short of target by
$610K (.2%) despite admissions flat to budget and surgery volume that fell just short of expectations, (44 procedures, 2.5% below
target). Med Surg supplies came in $150K (3.4%) below budget including a one-time $172K expense related to exiting the OSC joint
venture. Blood expense was under budget for the region with a wide variance of expense across the acute care sites. Supply expense
per EIPA finished slightly above budget, driven in part by extraordinary expense related to the flu response. Drug costs exceeded
budget by $30K (.5%) on Patient Days that were over plan by 1.8%. Cath Lab at SEYH remained strong with volumes exceeding budget
by 3% and prior-year by 28%. Overall implants came in signficantly under budget ($215K, 7%) on I/P surgeries that fell 175 (31%) short
of plan and strong volume at St. Elizabeth's Cath Lab (3.4% over budget). TAVR volume (7 procedures, $228K) was in-line with
recent volume trends and exceeded PY by two ($65K). Implant Other exceeded budget by $70K, mainly driven by CardioMEMS ($39K)
and Occluder PFO expense ($20K) as well as six EVAR/AAA procedures totaling $112K.
Key Challenges
$87K expensed on several high-dollar treatments/devices at SEYH Interventional Radiology
including $48K Sirtex SIR-sphere radiation therapy seeds (consider coding elsewhere) as well as
Youngstown Leader's Summary
11 ea. ($31K) in EKOS catheters
Significant increase in Intuitive Surgical expense compared to PY ($69K vs. $36K).
Med/Surg
Corresponding decrease in expense expected over next 2-3 months as instrument have 10-20
uses before requiring replacement.
Intuitive Surgical robotic surgery consumable expense exceeded PY by $106K on 58 additional
procedures (91 vs. 33 PY).
Drugs that saw a significant increase over PY included antineoplastic agents ($568K) and
thrombolytics ($124K).
Rx Decrease in expense was noted for antirheumatic agents ($185K) and hematopoietics ($51K)
At St. Elizabeth's, TAVR volume was in-line with budgeted expectations, no Intuity valves
installed vs. 3 ea. PY ($36K impact). ICD/pacers exceeded budget by 18K on similar volume to
PY. Two SICDs were implanted at a total cost of $52K
Boardman continues to experience total joint savings comapred to prior contract as evidenced
Implants
by average total knee replacement expense of $3,858 vs. $4,330 PY
Spinal implants at St. Joseph's were under budget by $68K (92.1%) on one primary neurostim
implants for the month. The facility did, however, implant five pain pumps totaling $47.500.
$21,425 reclassed from fixed asset to expense - Org 6176 Youngstown Physicians due to FF&E
entry from practice acquistion
Other Expenses $176K expense related to our exiting the OSC Surgery Center JV - expected one-time charge.
IV and IV set expense shows a wide variance from budget based on IV catheters and start kits
that were previously expensed to Med Surg supplies
Actions Taken/Planned:
Flu supply expenses were scrutinized with portions of late-month deliveries accrued to February
expense.
Blood transfer expense booking, St. Elizabeth's to sister sites is under review as current process
frequently results in wide expense variances by facility.
Medtronic DES trial is underway at St. Elizabeth's Cath Lab.